Cell density is a factor that affects the capacity of Cloudman $91 melanoma cells to respond to melanotropins in monolayer culture. Continuous exposure of melanoma cells to a-melanotropin or its potent analog [Nle 4, D-PheT]-a-MSH, resulted in maximal stimulation of tyrosinase after 2 d of treatment, but the magnitude of stimulation decreased thereafter despite the continued presence of the melanotropins. However, when melanoma cells continually exposed to melanotropins were subcultured to an initial low cell density and maintained in contact with a-MSH or [Nle', D-PheTI-a-MSH (tong-term culture), tyrosinase activity was rapidly restored and greatly enhanced. Also, when cells were seeded at initial densities ranging from 0.2 to 3.2 X 106 ceUs/flask, and exposed for 24 h to 10 -7 M a-MSI-I, only the cultures seeded at low densities (0.2 and 0.4 X 106 cells/flask) exhibited maximal tyrosinase activity during the 24 h exposure to the melanotropins. Therefore, tyrosinase activity was primarily affected by cell density rather than by the duration of time the ceils were in culture or by continuous exposure to melanotropin. Other flasks of various cell densities were treated with 10 -7 M a-MSH or [Nle 4, D-PheTI-a-MSH for 24 h, followed by removal of the melanotropins from the culture medium. The magnitude and duration of the residual stimulation of melanoma tyrosinase activity by melanotropins were also found to be dependent on the initial cell density. These results reveal that there is a limited range of optimal cell densities at which melanoma cells can respond to melanotropins and express increased tyrosinase activity.
INTRODUCTION
One function of a-melanotropin {a-melanocytestimulating hormone, a-MSH) is to regulate integumental pigmentation in many vertebrate species {8,20) . This tridecapeptide, Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-ArgTrp-Gly-Lys-Pro-Val-NI-I2, stimulates melanogenesis within normal as well as abnormal {malignant) melanocytes (6, 8, 14, 15) . Many of the processes involved in the mechanism of action of tr-MSH have been elucidated using murine $91 melanoma cells (14) . a-MSH binds to specific membrane receptors, resulting in stimulation of adenylate cyclase which, in turn, increases the intracellular levels of cyclic AMP, an effect that is detectable within 20 min after exposure of melanoma cells to the hormone. Elevated cyclic AMP levels lead to stimulation of tyrosinase, the rate-limiting enzyme of the melanin biosynthetic pathway, which eventually results in increased melanogenesis (14) .
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[Nle 4, D-PheT]-a-MSH is a superagonist that exhibits ultraprolonged action on both normal and abnormal melanocytes (9,18,19L This a-melanotropin analog is 100-fold more effective than r in stimulating $91 melanoma tyrosinase activity (10) . We have shown that the degree of tyrosinase stimulation by a-MSH and [Nle 4, D-PheT]-a-MSH is governed by at least two factors: the concentration of melanotropin and the time the melanotropin is in contact with the melanoma cells {10). Our studies involving continuous exposure of cells to melanotropins indicated that a third factor, namely, cell density, affects the magnitude of melanotropin-induced tyrosinase activity, as first reported by Fuller and Lebowitz (7) . We now provide data indicating that cell density at the time of melanotropin exposure also affects the magnitude of the residual (i.e. prolonged) tyrosinase activity after the melanotropins are removed from the culture flasks.
MATERIALS AND METHODS

Materials.
Ham's F10 medium, horse serum, fetal bovine serum, and penicillin-streptomycin solution were purchased from GIBCO Laboratories (Santa Clara, CA). Radioactive L-3',5'-[3H]-tyrusine (specific activity 53.0 Ci/mmol) was purchased from New England Nuclear (Boston, MA). a-MSH was obtained from Sigma Chemical Co. (St. Louis, MO). The melanotropin analog, [Nle', D-PheT]-a-MSH was synthesized in the laboratory of Dr. V. J. Hruby, Department of Chemistry, University of Arizona, according to previously published methods ( 18, 19) .
Cell culture. The murine $91 melanoma cell line, 3960, CCL 53.1, was obtained from the American Type Culture Collection Cell Repository (Rockville, MD). Periodically, ceils were injected subcutaneously into syngeneic mice (DBA/2J, Jackson Laboratories, ME) and the tumors formed were then excised, reduced to single cells, and cryopreserved in liquid nitrogen. Cells from the frozen stock were maintained in monolayer culture by limited weekly subculturing for a maximum of 10 passages. Cells were grown in Ham's F10 medium, supplemented with 10% horse serum, and 2% fetal bovine serum, both heat-inactivated at 56 ~ C for 30 min, and with 100U/mhl00 ~g/ml penicillin-streptomycin, and were incubated in a humidified incubator (5% CO2:95% air) at 37 ~ C.
Stimulation of melanoma tyrosinase by continuous melanotropin treatment.
Flasks were seeded at a density of 0.2 X ]06 cells/25-cm 2 flask, or at greater cell densities, in 4 ml of medium, and 24 h later (Day 2 of culture} were treated with 10 -7 M a-MSH or [Nle 4, D-PheT]-a-MSH. Twenty-four hours before data collection, the medium in a set of control and melanotropintreated flasks was changed and replaced with 4 ml of medium containing 1 /~Ci/ml [3H]-tyrosine. At the end of each consecutive 24-h incubation period, cultures that were maintained in the presence of medium containing [3H]-tyrosine were harvested using EDTA-containing Tyrode's solution, and the cells were counted with the aid of a hemacytometer. The labeled medium from each flask was collected daily for determination of tyrosinase activity from Days 2 to 10 in culture. To determine the effects of long-term culture and continuous melanotropin treatment, after 3 and 6 d of melanotropin contact (Days 4 and 7 in culture), some control and treated flasks were harvested and subcultured to the original initial cell density of 0.2 )< 106 cells/flask and immediately treated with melanotropins in the presence of labeled or unlabeled media. Tyrosinase activity was again determined for the initial 24-h exposure period after subculturing, and daily thereafter for 2 more d.
Residual stimulation of melanoma tyrosinase activity by melanotropins. Cells were seeded at a density of 0.2 X 106 ceils/25-cm 2 flask or greater, and treated 24 or 48 h later (on Day 2 or 3 in culture, respectively) with 10 -7 M a-MSH or [Nle', D-PheT]-ct-MSH for a 24-hr period. Then the melanotropins were removed from the culture flasks by rinsing several times with 4 ml of serum-free Ham's F10 medium until no melanotropic activity could be detected in the incubation medium by frog skin bioassay (2) . Melanotropin-stimulated tyrosinase activity during the 24-h exposure period was determined (To}. Daily measurements of prolonged (residual) tyrosinase stimulation began immediately after meianotropin removal by addition of Tyrosinase assay. A modification of the charcoal absorption method (6, 7, 24) developed by Pomerantz (16, 17) was used to determine tyrosinase activity. In this modified assay, the amount of 3H20 released into the culture medium by cells growing in situ, when [3H]-tyrosine was converted to L-Dopa during a 24-h period was measured. Earlier studies have shown that the release of 3Hz0 from cells growing in situ into the incubation medium parallels intraceilular tyrosinase (24) . Duplicate l-ml aliquots were taken from the medium in each flask and pipetted into glass test tubes. Each sample was then treated with 1 ml of activated charcoal (10% wt/vol in 0.2 N citric acid), vortexed and immediately centrifuged at 1300 X g. One milliliter of the supernatant was aliquoted from each tube and passed through a Dowex 50 W column, and each column was then rinsed with 1 ml of 0.1 N citric acid. The eluents were collected into scintillation vials, which then received 12 ml of scintillation fluid (tolune:Triton X-100, 2:1 vol/vol + 5.5 g diphenyloxazole/literL The vials were counted in a Beckman LS-8000 scintillation spectrometer. Data were presented as counts per minute (cpm) per million (106) cells, +_ SE, and also in units of nanomoles tyrosinase activity/lip cells/24 h. Treatment groups were determined to be different from control by Student's t-test. For some graphic presentations, data (cpm/lip cells) were expressed as a percent of control (100%), -4-SE. (1, 6) . Tyrosinase activities increased and reached maximal levels (approximately 20 X lIP cpm/lip cellM after 2 d of melanotropin treatment, with tyrosinase levels five to six-fold higher than control levels. The magnitude of both the basal and maximal tyrosinase activities was gradually diminished during Days 3 to 6 of exposure to either melanotropin (Fig. 2, solid lines) . Days 3 to 6 of melanotropin treatment corresponded to Days 4 to 7 in culture, demonstrating that the ability to stimulate $91 (CCL 53.1) melanoma tyrosinase with melanotropins was greatest during midlogarithmic growth (Days 3 and 4 after seeding) and diminished as ceils approached confluency.
RESULTS
Melanoma cell growth in culture.
Restoration of melanoma tyrosinase responsiveness after subculture. In the experiment described above ( (Fig. 2, third peak) .
On Day 7 of melanotropin treatment, 24 h after reducing cell density, the subeultured cells exhibited a further increase in the magnitude of the maximally achievable tyrosinase activity (51)< 103 cpm/106 cells) in the face of concurrent increases in basal enzyme activity (Fig. 2, third  peak and corresponding basal lines) . Again, enhanced tyrosinase activity gradually declined as cell density increased.
Melanotropin-stimulated tyrosinase activity of melanoma cells seeded at different initial densities.
To determine whether cell density, rather than duration in continuous culture, was responsible for the decreased responsiveness of melanoma cells to the melanotropins, cells were seeded at different initial densities and exposed to 10 -7 M a-MSH on Day 2 of culture for 24 h in the presence of [3Hl-tyrosine-labeled medium, and tyrosinase activity was determined at the end of this 24-h exposure (Fig. 3) . a-MSH increased tyrosinase activity three to four fold above the control level in flasks initially seeded at cell densities of 0.2 and 0.4 )< 106 cells/flask, but the magnitude of stimulation decreased proportionately with the increase in initial seeding density. A gradual decrease in basal tyrosinase activity oceured as initial seeding density increased (Fig. 3) . These results suggest that the decrease in the magnitude of the melanotropin-stimulated tyrosinase activity is influenced by cell density and is not related to insensitivity of the ceils due to continuous culture or prolonged treatment with melanotropins.
Effect of melanoma cell density on residual melanotropin action.
The possible effect of cell density on the magnitude of residual stimulation of tyrosinase activity by melanotropins was investigated. In one experiment, cells were seeded at 0.2 )< 106 cells/flask and exposed on the following day (Day 2 in culture) to 10 -7 M t~-MSH for 24 h. Then both control and treated cultures were rinsed twice so that the melanotropin was completely removed from the treated flasks. Tyrosinase activity was determined right at the end of the exposure period (24 h) to melanotropins (To) and every 24 h thereafter for Days 1 to 4 after melanotropin removal (Days 3 to 7 in culture). In the latter case, tyrosinase activity per 106 ceils was minimally increased on Day 1 after a-MSH was removed, and returned to basal level on Day 2 (Fig. 4) . Another set of flasks were seeded at the same density of 0.2 X 106 cells/flask, but were treated with the melanotropin on Day 3 (rather than Day 2) in continuous culture, and residual melanotropic activity was determined daily for Days 1 to 4 after melanotropin removal (Day 4 to 8 in DENSITY-DEPENDENT TYROSINASE 79 culture). In both cases, melanotropin-stimulated tyrosinase activities were equal in the presence of the hormone (To values; approximately 1.5-fold above control) whether the cells were exposed to the melanotropin on Day 2 or 3 in culture. In the latter case (treatment on Day 3 in culture), the residual effect of the hormone was quite dramatic, as tyrosinase activity was increased two to three fold above basal level and remained significantly higher than control level for all 4 d after melanotropin removal (Fig. 4L To determine the extent to which cell density affected differences in magnitude of residual tyrosinase stimulation, cells were seeded at initial densities of 0. (Fig. 2) .
Similar to our findings, Fuller and Lebowitz (7} previously reported that continuous exposure of Cloudman melanoma cells to a-MSH maximally stimulated tyrosinase activity by 48 h of exposure to the melanotropin, but the magnitude of stimulation decreased thereafter despite continuous cellular contact with the hormone and a doubling of the melanotropin concentration every day to compensate for the cell population doubling that occured every 24 h. Increasing the concentration of a-MSH did not prevent the decline in the stimulated enzyme levels, suggesting that the melanotropin concentration used in our experiments (10 -7 M) was not limiting to the cellular response in high-density cultures. We have also demonstrated that the stimulation of tyrosinase activity by a superpotent analog [Nle 4, D-Phe']-a-MSH, which is resistant to inactivation by serum enzymes (3, 4) , is affected by cell density as are the actions of the native melanotropin, a-MSH. Thus, the present experiments confirm that the decreased tyrosinase response to melanotropin treatment was not due to a decreasing availability of hormone.
The decreased cellular responsiveness to melanotropins may be attributed to one or more of the following factors: (a) melanotropin receptor down regulation due to prolonged exposure of the cells to melanotropins; (b) increased cell density with days in culture; or (c) the duration of the time the melanoma cells were in culture, or both (b) and (c). To determine if the gradual loss of responsiveness to melanotropins was due to down regulation of the melanotropin receptor, cells exposed to a-MSH or [Nle 4, D-PheT]-a-MSH for 3 or 6 consecutive d were suhcultured and seeded at 0.2 )< 106 cells/flask, and kept in continuous contact with the melanotropins. This resulted in an immediate restoration and enhancement of tyrosinase activity {Fig. 2). We have shown that as Cloudman $91 melanoma cultures approach confluency the proliferative rate slows (Fig. 1) , possibly because of increased cell cycle time or because of the arrest of some cells in Go phase. It has been proposed that $91 melanoma melanotropin receptors are only expressed during the G2 phase of the cell cycle (22) . If this is the case, then subculturing of high-density cultures to a low density may allow the cells to traverse the cell cycle and to gain express melanotropin receptors, thus regaining their responsiveness to melanotropins. Fuller and Lebowitz (7) noted that melanoma cells maintained at high density were refractory to a prostaglandin, a methylxanthine, and even to dibutyrl cyclic AMP, which suggests that the block to enhanced tyrosinase activity is localized to a point distal to cyclic AMP production, rather than at the mdanotropin receptor.
It has been demonstrated that some strains of $91 melanoma produce a tyrosinase inhibitor (5) . Hence, it has been suggested that ceils in high-density cultures produce a factor that inhibits tyrosinase expression. It is possible that such a factor may be diluted out when cell density is decreased, resulting in the restoration of responsiveness to melanotropins by cells in long-term culture, as seen in the present studies.
One interpretation for the incremental ir~creases in tyrosinase activity achieved after a reduction of cell density with continued exposure to the melanotropins is that the cells may have increased the synthetic machinery required for enhanced enzyme activity {e.g., endoplasmic reticulum, RNA) that can only be expressed when cell density is decreased. In one experiment, cells were seeded at different densities and were treated the next day with 10-' M a-MSH for 24 h (Fig. 3) . Similar to the results previously reported by Fuller and Lebowitz (7), maximal tyrosinase activation (four to five fold above basal level) was achieved in cultures seeded at 0.2 to 0.4 X 106 cells/flask, and at higher seeding densities the magnitude of the cellular response diminished (Fig. 3) . The results dearly demonstrate that cell density, rather than duration of time in culture is responsible for the decreased responsiveness of $91 melanoma cells to melanotropins, indicating that there is an optimal density at which melanoma cells can respond to melanotropin treatment with increased tyrosinase activity.
We have frequently observed that basal tyrosinase activity gradually decreased as the cells were maintained in continuous culture. The decrease in enzyme activity became evident after 4 to 5 d of maintenance in monolayer culture, as the cells approached plateau phase of logarithmic growth (Figs. 1 and 2) , which fits the Type I model of melanogenesis described by Oikawa et al. (12) . This decrease in basal tyrosinase activity was also related to cell density, rather than the duration of time in culture. This was evident because cells seeded into flasks at different initial densities, showed basal tyrosinase activities that were inversely proportional to the seeding density ( Fig. 3}(13) . In contrast to the $91 melanoma cell line utilized in our studies, two clones of B16 melanoma cells were reported to exhibit a progressive increase in enzyme activity during logarithmic growth and to achieve a maximum level at confluency {23), which fits the Type II model of melanoma cultures (12) .
When the prolonged actions of a-MSH were determined, a remarkable increase in the magnitude and duration of residual tyrosinase stimulation was observed when cells were treated on Day 3, rather than on Day 2 in culture {Fig. 4). To values were the same for cells treated on Day 2 or 3 in culture, yet the decline of tyrosinase activity of the cells exposed to a-MSH on Day 2 in culture was very rapid. This indicates that although the cells were able to respond equally in the presence of the melanotropin, their ability to maintain the response after the melanotropin was removed was a function of cell density.
To determine whether cell density rather than duration of time in culture was responsible for the observed differences in the magnitude and duration of residual stimulation, cells were seeded at different densities, treated after 24 h with 10-7 M a-MSH or [Nle 4, D-Phe']-a-MSH, and the prolonged effects of the melanotropins were determined 24 h after melanotropin removal (Fig. 5) . The results obtained indicate that cell density is a factor that also influences the magnitude of residual tyrosinase activation.
It has previously been documented that basal tyrosinase activity of melanoma cells, as well as enzyme activity stimulated by various melanogenic factors, such as cyclic AMP, theophylline, prostaglandin El, and a-MSH, are a function of cell density (7, 12, 13, 23) . The present study also emphasizes the importance of cell density as a factor that determines the immediate responsiveness of $91 melanoma cells to melanotropin stimulation, as well as a factor that influences the residual stimulation of tyrosinase activity by melanotropins. The present results may have implications for related studies on the response of other cell types to endocrine or related stimulation. For example, aside from the effect that cell density had on the phenotypic expression of $91 melanoma cells, plating density has also been shown to affect the proliferation of these cells and of human tumor cells in soft agar {11,21}. In the bilayer agar culture system the size of colonies formed by Cloudman melanoma cells was inversely related to the initial number of cells plated, indicating that there was an optimal range of plating densities at which maximal plating efficiency and melanotropin stimulation of proliferation {large colony formation} were evident (1).
